FDA Adverse Event Injury Summary report: N

NALU NEUROSTIMULATION SYSTEM

MDR report key: 20197573 · Received September 12, 2024

Report

Report Number
3015425075-2024-00332
Event Type
Injury
Date Received
September 12, 2024
Date of Event
August 1, 2024
Report Date
August 30, 2024
Manufacturer
NALU MEDICAL, INC
Product Code
GZF
UDI-DI
00812537036441
PMA / PMN Number
K183579
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THERE IS NO INDICATION OF ANY SYSTEM OR COMPONENT FAILURE. SURGICAL PROCEDURE WAS PERFORMED PER PATIENT REQUEST ONLY. PATIENT HAD INITIALLY AGREED UPON PLACEMENT OF THE IMPLANT AFTER PARTICIPATING IN A WEAR STUDY WHICH INCLUDES USE OF THE EXTERNAL DEVICES. THE IPG WAS REPLACED DURING THE PROCEDURE DUE TO POTENTIAL FOR HANDLING DAMAGE AND AS A PRECAUTION ONLY.

Description of Event or Problem · 0

PATIENT UNDERWENT A TRIAL WITH A COMPETITOR SYSTEM AND WAS THEN IMPLANTED WITH A NALU PERIPHERAL NERVE STIMULATOR SYSTEM ON 12/11/2023 TO TREAT HEAD PAIN. PRIOR TO IMPLANTING THE NALU SYSTEM, THE PATIENT PARTICIPATED IN A WEAR STUDY WITH NALU TO DETERMINE THE PATIENT'S PREFERENCE ON LOCATION OF THE DEVICE. PER THE WEAR STUDY RESULTS, THE IMPLANTABLE PULSE GENERATOR (IPG) WAS PLACED NEAR THE TRAPEZIUS AREA. AFTER USING THE SYSTEM, THE PATIENT NOTED THAT THE PLACEMENT OF THE IMPLANT CAUSED THE EXTERNAL PORTION TO CATCH HAIR AND CAUSE DISCOMFORT. PATIENT REQUESTED TO MOVE THE IMPLANT. ON (B)(6) 2024 THE EXISTING IPG WAS REMOVED AND A NEW ONE WAS PLACED CLOSER TO THE CERVICAL AREA. THE EXISTING LEADS REMAIN IN PLACE AND IN USE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1585315 NALU NEUROSTIMULATION SYSTEM PERIPHERAL NERVE STIMULATOR GZF NALU MEDICAL, INC 71019 00812537036441

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other